Platelet glycoprotein IIb/IIIa inhibitors.
Hellstrom
H Richard
HR
D000077284:Abciximab; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control; D015539:Platelet Activation / Q000187:drug effects*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013927:Thrombosis / Q000517:prevention & control; D014336:Troponin / Q000032:analysis
D000317:Adrenergic alpha-Antagonists; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014336:Troponin; D000077284:Abciximab